J Korean Ophthalmol Soc.  1987 Aug;28(4):905-908.

Management of Vitreous Opacity General Principles

Affiliations
  • 1Department of Ophthalmology, College of Medicine, Pusan National University, Pusan, Korea.

Abstract

The management of vitreous opacities varies from case to case. Successful treatment depends on identifying the specific cause of the opacity. In general, opacities which do not reduce vision are left alone; however, the condition producing the opacities is treated. Most congenital opacities seldom requires treatment, since they are usually asymptomatic and innocuous. In case of vitreous opacity caused by uveitis, specific therapy or steroid therapy is needed. The management of hemorrhagic vitreous opacity depends on whether the hemorrhage is recent or long-standing. A patient with a recent vitreous hemorrhage of unknown etiology should be placed on strict bed rest at least 72 hours. Retinal break or vascular lesions causing vitreous hemorrhages should be treated with photocoagulation, cryoapplication or scleral buckling procedure. When vitreous hemorrhage does not clear in 6 months, a closed vitrectomy may be indicated. Dense, organized intravitreous opacities of hemorrhagic or inflammatory origin are permanent and these opacities can be removed through a closed vitrectomy.


MeSH Terms

Bed Rest
Hemorrhage
Humans
Light Coagulation
Retinal Perforations
Scleral Buckling
Uveitis
Vitrectomy
Vitreous Hemorrhage
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr